DTaP poliovirus vaccine (Sanofi)

N/A

Report date: 2025/08/13 20:02:02

Base Information

Drug NameDTaP poliovirus vaccine (Sanofi)
Drug Alias NameDTacP-IPV combined vaccine - SanofiTetravacTetraxim
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4
Global Approved IndicationsPoliomyelitisTetanusDiphtheria +[4
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date1998/01/30
Country/TerritorySwedenSouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Inactive CompaniesSanofi
Active IndicationsPoliomyelitisTetanusDiphtheria +[4
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA02
Related LinksN/A